Stock RPH S.C. ROPHARMA S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials S.C. Ropharma S.A.

Equities

RPH

ROIAFRACNOR4

Drug Retailers

End-of-day quote Bucharest S.E.
Other stock markets
 23:00:00 25/06/2024 BST 		5-day change 1st Jan Change
0.195 RON -3.47% Intraday chart for S.C. Ropharma S.A. -5.34% -2.50%
04-25 S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 178.9 140.6 117.2 106 95.61 102.3
Enterprise Value (EV) 1 237.2 274.2 248.6 232.2 228.5 249.8
P/E ratio 14.7 x 19.1 x 17.4 x - 10.4 x 13.2 x
Yield - - - - - -
Capitalization / Revenue 0.28 x 0.18 x 0.15 x 0.12 x 0.1 x 0.09 x
EV / Revenue 0.37 x 0.35 x 0.31 x 0.26 x 0.23 x 0.22 x
EV / EBITDA 11.2 x 14.5 x 9.92 x 7.4 x 9.45 x 6.9 x
EV / FCF 38.9 x -27.4 x -33.7 x -65.2 x 22.1 x 15.8 x
FCF Yield 2.57% -3.65% -2.96% -1.53% 4.53% 6.31%
Price to Book 1.03 x 0.79 x 0.59 x - 0.41 x 0.43 x
Nbr of stocks (in thousands) 511,267 498,499 509,742 509,736 511,267 511,267
Reference price 2 0.3500 0.2820 0.2300 0.2080 0.1870 0.2000
Announcement Date 25/04/19 30/04/20 28/04/21 28/04/22 27/04/23 25/04/24
1RON in Million2RON
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 636.2 783.7 805.9 888.2 1,002 1,120
EBITDA 1 21.23 18.89 25.06 31.36 24.18 36.2
EBIT 1 11.59 8.701 10.55 17.11 9.256 20.02
Operating Margin 1.82% 1.11% 1.31% 1.93% 0.92% 1.79%
Earnings before Tax (EBT) 1 14.76 6.689 6.637 13.53 10.32 13.69
Net income 1 12.12 7.523 6.753 10.73 9.216 7.718
Net margin 1.9% 0.96% 0.84% 1.21% 0.92% 0.69%
EPS 2 0.0237 0.0148 0.0132 - 0.0180 0.0151
Free Cash Flow 1 6.104 -10 -7.366 -3.56 10.35 15.77
FCF margin 0.96% -1.28% -0.91% -0.4% 1.03% 1.41%
FCF Conversion (EBITDA) 28.74% - - - 42.8% 43.57%
FCF Conversion (Net income) 50.36% - - - 112.29% 204.36%
Dividend per Share - - - - - -
Announcement Date 25/04/19 30/04/20 28/04/21 28/04/22 27/04/23 25/04/24
1RON in Million2RON
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 58.2 134 131 126 133 148
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.743 x 7.076 x 5.241 x 4.022 x 5.496 x 4.076 x
Free Cash Flow 1 6.1 -10 -7.37 -3.56 10.3 15.8
ROE (net income / shareholders' equity) 7.17% 2.53% 2.37% 5.49% 3.31% 4.81%
ROA (Net income/ Total Assets) 1.71% 0.93% 1% 1.62% 0.8% 1.59%
Assets 1 710.4 805.7 678.7 661.5 1,145 486.7
Book Value Per Share 2 0.3400 0.3600 0.3900 - 0.4500 0.4700
Cash Flow per Share 2 0.0200 0.0200 0.0300 - 0.0300 0.0300
Capex 1 16.4 27 12 17.6 10.4 16.2
Capex / Sales 2.57% 3.44% 1.49% 1.99% 1.04% 1.44%
Announcement Date 25/04/19 30/04/20 28/04/21 28/04/22 27/04/23 25/04/24
1RON in Million2RON
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Retail - Drugs with Grocery

1st Jan change Capi.
S.C. ROPHARMA S.A. Stock S.C. Ropharma S.A.
-2.50% 21.39M
COSMOS PHARMACEUTICAL CORPORATION Stock COSMOS Pharmaceutical Corporation
-19.86% 3.25B
TSURUHA HOLDINGS INC. Stock Tsuruha Holdings Inc.
-28.53% 2.84B
SUGI HOLDINGS CO.,LTD. Stock Sugi Holdings Co.,Ltd.
+4.99% 2.47B
LBX PHARMACY CHAIN Stock LBX Pharmacy Chain
-16.49% 2.14B
KUSURI NO AOKI HOLDINGS CO., LTD. Stock Kusuri No Aoki Holdings Co., Ltd.
-6.58% 1.78B
CREATE SD HOLDINGS CO., LTD. Stock Create SD Holdings Co., Ltd.
+19.41% 1.46B
GREAT TREE PHARMACY CO., LTD. Stock Great Tree Pharmacy Co., Ltd.
-31.47% 868M
SHUYU CIVILIAN PHARMACY CORP., LTD. Stock ShuYu Civilian Pharmacy Corp., Ltd.
-51.69% 560M
FARMACIAS BENAVIDES, S.A.B. DE C.V. Stock Farmacias Benavides, S.A.B. de C.V.
-0.53% 425M
Retail - Drugs with Grocery
  1. Stock Market
  2. Equities
  3. RPH Stock
  4. Financials S.C. Ropharma S.A.